CME Stock Options

CME Stock  USD 266.49  2.91  1.10%   
CME's latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.4 with a put-to-call open interest ratio of 0.28 over 44 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on June 20th 2025. The total put volume is at 299, with calls trading at the volume of 297. This yields a 1.01 put-to-call volume ratio.

Open Interest Against June 20th 2025 Option Contracts

The chart above shows CME's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. CME's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for CME's option, there is no secondary market available for investors to trade.

CME Maximum Pain Price Across 2025-06-20 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as CME close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, CME's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on CME

Analyzing CME's in-the-money options over time can help investors to take a profitable long position in CME regardless of its overall volatility. This is especially true when CME's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money CME's options could be used as guardians of the underlying stock as they move almost dollar for dollar with CME's stock while costing only a fraction of its price.
CME's stock options are financial instruments that give investors the right to buy or sell shares of CME Group common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell CME stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If CME's stock price goes up or down, the stock options follow.
At present, CME's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting.

CME Group In The Money Call Balance

When CME's strike price is surpassing the current stock price, the option contract against CME Group stock is said to be in the money. When it comes to buying CME's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on CME Group are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

CME Current Options Market Mood

CME's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps CME Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most CME's options investors are not very successful. CME's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current CME contract

Base on the Rule 16, the options market is currently suggesting that CME Group will have an average daily up or down price movement of about 0.025% per day over the life of the 2025-06-20 option contract. With CME trading at USD 266.49, that is roughly USD 0.0666. If you think that the market is fully incorporating CME's daily price movement you should consider buying CME Group options at the current volatility level of 0.4%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing CME options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" CME calls. Remember, the seller must deliver CME Group stock to the call owner when a call is exercised.

CME Option Chain

When CME's strike price is surpassing the current stock price, the option contract against CME Group stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
CME's option chain is a display of a range of information that helps investors for ways to trade options on CME. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for CME. It also shows strike prices and maturity days for a CME against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
CME250620C0033000050330.00.0 - 2.30.05Out
Call
CME250620C003200000320.00.0 - 2.752.75Out
Call
CME250620C0031000026310.00.0 - 4.81.16Out
Call
CME250620C0030000015300.00.0 - 4.81.25Out
Call
CME250620C00290000176290.00.2 - 4.51.75Out
Call
CME250620C00280000273280.04.0 - 5.64.4Out
Call
CME250620C00270000484270.06.5 - 9.08.1Out
Call
CME250620C002600001166260.013.3 - 14.813.8In
Call
CME250620C002500001347250.019.9 - 21.820.72In
Call
CME250620C002400001601240.027.1 - 29.728.8In
Call
CME250620C002300001297230.036.7 - 38.432.9In
Call
CME250620C0022000089220.045.6 - 48.242.1In
Call
CME250620C00210000542210.055.3 - 58.348.0In
Call
CME250620C0020000033200.064.6 - 68.165.85In
Call
CME250620C001950001171195.069.5 - 72.961.17In
 Put
CME250620P003300000330.064.0 - 68.564.0In
 Put
CME250620P003200000320.054.4 - 58.769.7In
 Put
CME250620P003100000310.044.0 - 48.244.0In
 Put
CME250620P003000000300.034.0 - 38.734.0In
 Put
CME250620P002900001290.025.0 - 28.832.3In
 Put
CME250620P002800000280.017.0 - 21.317.0In
 Put
CME250620P0027000021270.011.1 - 14.617.8In
 Put
CME250620P0026000017260.07.2 - 8.88.0Out
 Put
CME250620P00250000116250.04.1 - 5.37.06Out
 Put
CME250620P00240000160240.02.4 - 3.53.2Out
 Put
CME250620P00230000514230.01.35 - 2.051.85Out
 Put
CME250620P00220000273220.00.7 - 1.251.11Out
 Put
CME250620P00210000228210.00.35 - 1.051.35Out
 Put
CME250620P0020000086200.00.0 - 2.550.55Out
 Put
CME250620P0019500096195.00.0 - 1.50.45Out
 Put
CME250620P0019000049190.00.0 - 2.30.35Out
 Put
CME250620P0018500066185.00.1 - 3.70.42Out
 Put
CME250620P0018000045180.00.0 - 2.350.45Out
 Put
CME250620P0017500058175.00.0 - 4.81.9Out
 Put
CME250620P00170000378170.00.0 - 4.80.45Out
 Put
CME250620P0016500034165.00.0 - 4.80.38Out
 Put
CME250620P0016000041160.00.0 - 4.80.3Out
 Put
CME250620P0015500060155.00.0 - 4.80.4Out
 Put
CME250620P001500005150.00.0 - 4.80.67Out
 Put
CME250620P001450003145.00.0 - 4.81.2Out
 Put
CME250620P001400003140.00.0 - 4.81.63Out
 Put
CME250620P0013500028135.00.0 - 1.50.18Out
 Put
CME250620P001300001130.00.0 - 4.81.45Out
 Put
CME250620P001100006110.00.0 - 4.80.17Out

CME Market Cap Over Time

   Market Cap   
       Timeline  

CME Total Stockholder Equity

Total Stockholder Equity

18.02 Billion

At present, CME's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

CME Corporate Directors

Hilda PiellChief Human Resource Officer, Senior Managing DirectorProfile
Jack TobinChief Accounting Officer, Managing DirectorProfile
Derek SammannSenior Managing Director - Financial Products and ServicesProfile
Julie WinklerSenior Managing Director - Research and Product DevelopmentProfile
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Financial Exchanges & Data space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.072
Dividend Share
4.6
Earnings Share
9.67
Revenue Per Share
17.03
Quarterly Revenue Growth
0.06
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.